Mirati Therapeutics, Inc. is a clinical-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. The company is relentlessly focused on bringing forward therapies that address areas of high unmet medical need, including lung cancer, and advancing a pipeline of novel therapeutics targeting the genetic and immunological drivers of cancer. Unified for patients, Mirati's vision is to unlock the science behind the promise of a life beyond cancer.
For more information about Mirati Therapeutics Inc., visit us at Mirati.com.
Read our guidelines for interacting with Mirati on social media here: https://bit.ly/3lFIWB0.
|
|
|
201-500 employees
View all Mirati Therapeutics employees
|
|
Biotechnology
|
|
3545 Cray Ct, San Diego, California 92121, US
|
|
2013
|
David Meek is the CEO of Mirati Therapeutics. To contact David Meek email at [email protected].
The decision makers in Mirati Therapeutics are David Meek, David Rubin, James Christensen, etc. Click to Find Mirati Therapeutics decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.